PODD
Insulet CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$11.87B
P/E Ratio
50.26
EPS
$3.41
Beta
1.20
52W High
$354.88
52W Low
$158.35
50-Day MA
$214.38
200-Day MA
$281.49
Dividend Yield
—
Profit Margin
9.12%
Forward P/E
27.78
PEG Ratio
0.97
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.71B |
| Gross Profit (TTM) | $1.94B |
| EBITDA | $564.20M |
| Operating Margin | 18.70% |
| Return on Equity | 18.10% |
| Return on Assets | 9.43% |
| Revenue/Share (TTM) | $38.50 |
| Book Value | $21.53 |
| Price-to-Book | 8.00 |
| Price-to-Sales (TTM) | 4.38 |
| EV/Revenue | 4.564 |
| EV/EBITDA | 25.26 |
| Quarterly Earnings Growth (YoY) | 3.90% |
| Quarterly Revenue Growth (YoY) | 31.20% |
| Shares Outstanding | $69.26M |
| Float | $70.10M |
| % Insiders | 0.31% |
| % Institutions | 105.46% |
Historical Volatility
HV 10-Day
82.71%
HV 20-Day
59.66%
HV 30-Day
51.29%
HV 60-Day
44.98%
HV Rank
88.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($326.35 target)
5
Strong Buy17
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026